Skip to content

The Feasibility of Engage Therapy With Video Support for Homebound Older Adults

A Pilot Study of Delivering 'Engage' Psychotherapy Via Telemedicine Through the Tablet-based 'Prism' System to Homebound Older Adults With Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05346055
Enrollment
8
Registered
2022-04-26
Start date
2022-05-12
Completion date
2022-09-30
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Older Adults

Brief summary

The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.

Detailed description

Engage is a brief therapy designed to offer a structured, stepped approach and interventions to reduce barriers to increased engagement with rewarding activities to improve depression (Alexopoulos et al, 2020). The goal is to increase participation in meaningful activities. Homebound older adults have limited social interaction given their restricted mobility and medical burden. In prior research with an intervention targeting social engagement with a technology intervention (PRISM 2.0), participants reported increased social support, decreased loneliness, increased feelings of well-being, more positive attitudes about computers, and gains in computer proficiency (Czaja et al., 2017). Participants will be referrals from case management service. Clinicians will incorporate elements of the Prism system into therapy as appropriate, and participants will be instructed to use the Prism system at their leisure or as it pertains to their chosen reward exposure activities. There will be a post-therapy assessment and interview about their experience with the technology at week 9. The study will conclude with follow-up assessments at week 12.

Interventions

BEHAVIORALEngage Prism (2.0)

Brief Behavioral Treatment for Depression (Engage) combined with tablet-based social support system (Prism 2.0)

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age at least 60 years * English speaking * Currently enrolled in case management at in 2 included agencies * Major depression on the SCID * 24-item Hamilton Depression Rating Scale (HAM-D) ≥ 19

Exclusion criteria

* Psychotic depression by SCID-V, i.e. presence of delusions * High suicide risk, i.e. intent or plan to attempt suicide in the near future * Presence of any Axis I psychiatric disorder * Presence of substance abuse other than unipolar major depression * History of psychiatric disorders, hypomania, are excluded * Acute or severe medical illness, i.e. delirium, metastatic cancer, decompensated cardiac, liver, or kidney failure, major surgery, stroke, or myocardial infarction during the three months prior to entry; or drugs often causing depression, e.g. steroids, reserpine, alpha- methyl-dopa, tamoxiphen, vincristine * Current involvement in psychotherapy * Cognitive impairment (i.e. telephone administered MoCA \< 11) * Currently dwelling in non-community dwelling (e.g. prison, nursing home) * Hearing that would not allow participants to complete sessions with the RA/therapist * Vision impairment that would not allow the participant to use the study provided tablet * Inability to speak English * Aphasia interfering with communication * Literacy -assessed by reading a paragraph designed for those at 6th grade reading level

Design outcomes

Primary

MeasureTime frameDescription
Acceptability: Client Satisfaction Questionnaire (CSQ)6 weeks (part-way through treatment)The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided partway through the treatment (6 weeks). Scores range from 3 (least satisfied) to 12 (most satisfied).
Feasibility: Client EnrollmentBaselineFeasibility will be measured as the number of clients who are referred to the program, meet eligibility and accept the intervention (versus refuse).

Secondary

MeasureTime frameDescription
Hamilton Depression Rating ScaleBaseline, 9 weeks (end of treatment)Change in depression scores from Baseline to 9 weeks. Scores range from 0 (no depression) to 54 (very severe depression).

Countries

United States

Participant flow

Recruitment details

Participants were recruited from the Virtual Senior Center, a community-building platform that helps older and homebound adults connect and engage with each other through virtual and hybrid classes. Recruitment efforts included online message board posts, emails, and virtual information sessions (via Zoom). Prospective participants contacted a study team member via phone or email and completed screening via phone. Participants were recruited between April 1, 2022 and June 30, 2022.

Participants by arm

ArmCount
Engage Prism 2.0
Engage Prism is a 9-week program that integrates Engage- a form of behavioral talk therapy treating depression, and guided use of Prism technology- a software that aims to improve social support and interaction of older adults. Engage Prism (2.0): Brief Behavioral Treatment for Depression (Engage) combined with tablet-based social support system (Prism 2.0)
8
Total8

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Violation1
Overall StudyTherapist decision1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicEngage Prism 2.0
Age, Continuous73.88 years
STANDARD_DEVIATION 6.58
Race/Ethnicity, Customized
Black/African American
1 Participants
Race/Ethnicity, Customized
White
7 Participants
Region of Enrollment
United States
8 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 8
other
Total, other adverse events
0 / 8
serious
Total, serious adverse events
0 / 8

Outcome results

Primary

Acceptability: Client Satisfaction Questionnaire (CSQ)

The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided partway through the treatment (6 weeks). Scores range from 3 (least satisfied) to 12 (most satisfied).

Time frame: 6 weeks (part-way through treatment)

Population: All participants completing the study were analyzed, although one participant is not included due to a database error. Those who did not complete the study could not complete the post-study CSQ.

ArmMeasureValue (MEAN)Dispersion
Engage Prism 2.0Acceptability: Client Satisfaction Questionnaire (CSQ)10.5 score on a scaleStandard Deviation 4.34
Primary

Acceptability: Client Satisfaction Questionnaire (CSQ)

The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided assessed at 3 weeks post treatment (at 12 weeks) Scores range from 3 (least satisfied) to 12 (most satisfied).

Time frame: 12 weeks (post treatment)

Population: Five total participants completed the study and 12-week follow up. Only 2 are included as three records were lost due to a databases error.

ArmMeasureValue (MEAN)Dispersion
Engage Prism 2.0Acceptability: Client Satisfaction Questionnaire (CSQ)9 score on a scaleStandard Deviation 0
Primary

Feasibility: Client Enrollment

Feasibility will be measured as the number of clients who are referred to the program, meet eligibility and accept the intervention (versus refuse).

Time frame: Baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Engage Prism 2.0Feasibility: Client Enrollment8 Participants
Secondary

Hamilton Depression Rating Scale

Change in depression scores from Baseline to 9 weeks. Scores range from 0 (no depression) to 54 (very severe depression).

Time frame: Baseline, 9 weeks (end of treatment)

Population: Five participants completed this phase of the treatment, but only 3 are included as 2 were lost due to a database error.

ArmMeasureValue (MEAN)Dispersion
Engage Prism 2.0Hamilton Depression Rating Scale8.67 difference in pre/post score on a scaleStandard Deviation 2.52
Secondary

Hamilton Depression Rating Scale

Change in depression score from Baseline to 12 weeks post treatment. Scores range from 0 (no depression) to 54 (very severe depression).

Time frame: Baseline, 12 weeks (post treatment)

Population: Five participants completed this phase of the treatment, but only 2 are included as 3 were lost due to a database error.

ArmMeasureValue (MEAN)Dispersion
Engage Prism 2.0Hamilton Depression Rating Scale0.5 difference in pre/post score on a scaleStandard Deviation 0.707

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026